A comprehensive analysis of Glasgow Prognostic Score ( <scp>GPS</scp> )/the modified Glasgow Prognostic Score ( <scp>mGPS</scp> ) on immune checkpoint inhibitor efficacy among patients with advanced cancer-Reference-Cited by-同舟云学术

A comprehensive analysis of Glasgow Prognostic Score ( GPS )/the modified Glasgow Prognostic Score ( mGPS ) on immune checkpoint inhibitor efficacy among patients with advanced cancer

Published:2022-06-15 Issue:1 Volume:12 Page:38-48
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Zhang Yongchao¹,Chen Shanshan¹,Chen Hualei¹,Li Wei¹^ORCID

Affiliation:

1. Cancer Center, Beijing Ditan Hospital Capital Medical University Beijing People's Republic of China

Funder

Beijing Talents Fund

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.4940

Reference35 articles.

1. Clinical Challenges of Immune Checkpoint Inhibitors

2. Failure of Immunotherapy—The Molecular and Immunological Origin of Immunotherapy Resistance in Lung Cancer

3. Molecular mechanisms of resistance to immune checkpoint inhibitors in melanoma treatment: an update;Vukadin S;Biomedicine,2021

4. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prevalence and prognostic value of systemic inflammation in good performance status patients with advanced, inoperable non‐small cell lung cancer receiving palliative radiotherapy: Comparison of composite ratios and cumulative scores;Cancer Medicine;2024-08

2. Combining dynamics of serum inflammatory and nutritional indicators as novel biomarkers in immune checkpoint inhibitor treatment of non-small-cell lung cancer with bone metastases;International Immunopharmacology;2024-07

3. Association of pretreatment neutrophil-to-lymphocyte ratio with clinical outcomes in cancer immunotherapy: An evidence synthesis from 30 meta-analyses;International Immunopharmacology;2024-05

4. The prognostic value and model construction of inflammatory markers for patients with non-small cell lung cancer;Scientific Reports;2024-03-30

5. Prognostic scores in pulmonary large cell neuroendocrine carcinoma: A retrospective cohort study;Heliyon;2024-02